In the first blog of this series, we broached the complexities of the "Assess and Analyze" phase, emphasizing the importance of a thorough understanding of the regulatory landscape and an introspective look at one's organizational capabilities. As we move from the analytical to the actionable, the transition to the "Decision Making" phase is where the strategic planning crystallizes into tangible pathways. Organizations are now confronted with a pivotal choice: whether to nurture internal resources to meet regulatory challenges head-on or to articulate detailed specifications for selecting an external partner capable of propelling projects past the finish line—not merely for compliance's sake but for strategic technological empowerment and business enablement.
This juncture in the compliance timeline is not to be taken lightly. With the assess and analyze phase serving as the backbone of informed decision-making, payers are better positioned to navigate the waters of the decision-making phase, which in order to meet deadlines, should be in full swing towards the end of the year to allow the majority of 2025 for implementation, setting a steady course towards the 2026 finish line.
The regulations themselves hint at the urgency and precision required in this phase. In the past, when the initial CMS rules were released, they came with stringent decision timelines. The need for rapid decisions, sometimes within a mere three to seven days, presented a herculean challenge, but also a subtle nudge towards modernization and efficiency through automation. The very concept of these timeframes is not just a regulatory hurdle but a strategic enabler, pushing organizations towards embracing technological solutions. The rule itself contains considerable verbiage to explain and promote the benefits of APIs above and beyond the uses required.
The decision-making phase, therefore, is not merely a step in the compliance process; it is a leap towards future-proofing the organization. It’s a deliberate move to align with not only the regulatory demands of today but the technological imperatives of tomorrow. As we engage with this phase, the essence of strategic decision-making is to recognize that the choice between internal development and external partnership will significantly shape the organization’s operational agility and its place in the broader healthcare ecosystem.
For those organizations embarking on this critical phase, remember that the choices you make today are the building blocks for tomorrow’s successes. As you position yourselves at this crossroads, consider how the investments in technology and partnerships made today will unlock potential and create value that extends far beyond mere compliance.
As we close the chapter on our strategic exploration of the Decision-Making phase, it's evident that the steps organizations take today are pivotal for compliance success and long-term technological advancement. If your organization stands at the crossroads, weighing the decision to either build internal capabilities or partner externally, remember that this is not just a regulatory checkpoint but a strategic inflection point. For those in need of expert guidance to navigate these waters, support is just an email away. Reach out to me at brain.dwyer@pocp.com to set up a brief chat. We can discuss the type of assistance you might need to propel your organization through this crucial phase. Don't hesitate to secure the expertise that can illuminate the path to compliance and beyond.
Watch Full HIT Policy Pulse Webinar
Watch our expert-led session on the latest CMS rule. Understand and leverage compliance for strategic benefits.
Watch Now or Get the PDF of the slides to explore later.
Is 2024 the Year of the Pharmacist?
Harnessing the Potential of Pharmacy Interoperability & Advanced Practice
May 29, 2024
12 - 1 PM ET
